OAKLAND, Calif., May 17, 2022 /PRNewswire/ — Vertosa, a science-first cannabis company that creates the most effective and reliable active ingredients for infused products, today announced that it has entered into a research partnership with the University of Massachusetts Amherst (UMass Amherst). Through this initiative, Vertosa will offer its internal insights, resources and raw materials to support UMass’s studies regarding the nutritional applications of cannabigerol (CBG), a minor cannabinoid with potential therapeutic effects. Moreover, CBG interactions with one’s diet is a central focus of this research.
Vertosa and UMass Amherst’s collaborative venture is spearheaded by Dr. David Sela, an Associate Professor at the university’s Department of Food Science. Dr. Sela’s body of research largely focuses on nutrition, and more specifically, how one’s diet influences the human microbiome at various stages of life. Throughout his career, Dr. Sela has conducted postdoctoral research at the University of California, Davis and Stanford University while publishing over 60 studies. The initial studies on cannabinoids are led by Galaxie Story, a registered dietitian and PhD candidate conducting research in The Sela Lab. Her research focus ranges from the examination of host-microbial interactions to how plant bioactives, such as CBD, could impact gastrointestinal health through the gut-brain axis. Other key UMass personnel on the research team include Dr. Julian McClements, a Distinguished Professor from the Department of Food Science and Dr. Carrie-Ellen Briere, an Assistant Professor from the College of Nursing.
Together, Vertosa and UMass Amherst will study the pharmacokinetics and pharmacodynamics of cannabinoids in cannabis and cannabis-infused products. Vertosa’s latest research endeavor supports its mission to unlock the scientifically-backed healing power of the cannabis plant by making it approachable and accessible to all. In September 2021, Vertosa appointed Dr. Julian McClements as a Founding Member of its Science Advisory Board to enhance the company’s ability to develop efficacious, industry-leading cannabis ingredients and products.
“Our knowledge of cannabis and cannabis-infused products continues to evolve each day, and I am excited to learn more about this plant with boundless potential,” said Dr. David Sela, Associate Professor at the University of Massachusetts Amherst. “Our department is eager to partner with a cannabis company that is deeply invested in understanding the nuances of this plant and applying these insights to potentially support the health and well-being of people around the country.”
“As we strive to maintain our position as the industry’s leading ingredient supplier, we are thrilled to collaborate with UMass Amherst’s distinguished food science researchers,” said Ben Larson, Chief Executive Officer of Vertosa. “Dr. Sela and his team bring a wealth of knowledge to this field, and we are confident that their findings will not only create more R&D opportunities within the cannabis industry, but also spur further scientific research into the plant’s medical applications.”
For more information regarding Vertosa’s research partnerships and other endeavors, please visit https://vertosa.com/.
About Vertosa
Founded in 2018, Vertosa is a science-first cannabis company that creates the most effective and reliable active ingredients for infused products. Its patented and patent-pending emulsion systems are carefully designed for the specific needs of each customer, with pre-suspended aqueous solutions that create incredibly homogeneous and stable products while maximizing bioavailability, clarity and taste. Vertosa works closely with its lab partners and brands of all sizes throughout the manufacturing process to achieve target potency and accelerate products to market. Learn more at www.vertosa.com, and connect on LinkedIn and Instagram.
SOURCE Vertosa
Source: Globenewswire